EZH2-Dependent Suppression of a Cellular Senescence Phenotype in Melanoma Cells by Inhibition of p21/ <i>CDKN1A</i> ExpressionTao Fan, Thomas J. Hornyak|Molecular Cancer Research|2011Cited by 191
17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma modelSandeep S. Joshi, Thomas J. Hornyak|PLoS ONE|2018Cited by 15